---

ANSWER 1: Classification of Diuretics + Mechanism, Uses & Side Effects of High Ceiling (Loop) Diuretics

---

Part A: Classification of Diuretics

1. High Ceiling (Loop) Diuretics

• Furosemide (most common), Bumetanide, Torsemide, Ethacrynic acid

2. Thiazide Diuretics

• Hydrochlorothiazide, Chlorthalidone, Metolazone, Indapamide

3. Potassium-Sparing Diuretics

• Spironolactone, Eplerenone (aldosterone antagonists)
• Triamterene, Amiloride (direct ENaC blockers)

4. Carbonic Anhydrase Inhibitors

• Acetazolamide

5. Osmotic Diuretics

• Mannitol, Glycerol

6. Vasopressin (ADH) Antagonists

• Tolvaptan, Conivaptan

---

Part B: High Ceiling (Loop) Diuretics - Detail

Why "High Ceiling"?

---

Mechanism of Action

• Normally, this transporter reabsorbs Na+, K+, and Cl- from the tubular lumen into renal medullary cells, building up the hypertonic medullary gradient that drives water reabsorption.
• By blocking this transporter, loop diuretics:
  1. Prevent reabsorption of Na+, K+, and Cl- into the medulla
  2. Lower the osmotic pressure of the medulla
  3. Reduce water reabsorption from water-permeable segments (e.g., collecting duct)
  4. Result in a large volume of dilute urine

---

Uses (Therapeutic Indications)

---

Side Effects

• Lippincott Illustrated Reviews: Pharmacology, p. 341-342

---

Pharmacokinetics Summary

---

---

ANSWER 2: Principles and Indications of Peritoneal Dialysis + Precautions

---

Principles of Peritoneal Dialysis

Three Core Physical Principles:

• Waste products (urea, creatinine, potassium, phosphate) move from the blood (high concentration) across the peritoneal membrane into the dialysate (low concentration) - down the concentration gradient.
• This is the primary mechanism for solute removal.

• The dialysate solution contains a high concentration of glucose (or icodextrin) as an osmotic agent.
• Water moves from the blood (lower osmolality) into the dialysate (higher osmolality), removing excess fluid from the body.
• Different glucose concentrations (1.5%, 2.5%, 4.25%) are used to regulate the amount of fluid removed.

• As water is ultrafiltered, it carries dissolved solutes along with it (solute drag), supplementing diffusion especially for larger molecules.

How It Works in Practice (CAPD):

1. A soft Tenckhoff catheter is permanently placed into the peritoneal cavity (between visceral and parietal peritoneum, near the pouch of Douglas)
2. Dialysate (~2 litres) is instilled into the abdomen and dwells for 4-8 hours
3. During dwell time, waste products and water move across the peritoneum
4. The dialysate is then drained and fresh dialysate is instilled
5. This cycle is repeated 3-5 times per day (CAPD) or automated overnight (APD)

• Brenner and Rector's The Kidney

---

Indications for Peritoneal Dialysis

---

Precautions During Peritoneal Dialysis

Pre-Procedure Precautions:

• Catheter should not be used for 10-14 days after placement to allow wound healing
• Exit site must face downward and laterally to prevent infection
• Avoid placing catheter at the beltline, prior surgical sites, or abdominal midline
• PD is usually started 2-4 weeks after catheter placement

During Procedure:

• Strict aseptic technique to prevent peritonitis (most serious complication)
• Monitor fluid balance carefully - track inflow vs. outflow volumes
• Use appropriate glucose concentration dialysate based on fluid removal needs
• Avoid using glucose dehydrogenase pyrroloquinoline quinone (GDH-PQQ) based glucose monitors in PD patients using icodextrin (gives falsely elevated readings - risk of insulin overdose and hypoglycemia)
• Monitor for signs of infection at exit site

Ongoing Precautions:

• Catheter should be flushed 2-3 times per week with saline or dialysate until patient starts PD
• Cover catheter with non-occlusive dressing
• Watch for protein loss across the membrane (nutritional supplementation may be needed)
• Monitor glucose in diabetic patients - glucose absorption from dialysate causes calorie gain and worsening glycemic control
• Watch for ultrafiltration failure over time due to membrane changes (from glucose degradation products and advanced glycation end-products)
• Swan-neck catheter design is preferred - reduces cuff extrusion and lowers infection risk compared to straight Tenckhoff catheters
• Brenner and Rector's The Kidney, p. 2914

---

---

ANSWER 3: Synthesis, Absorption, and Pharmacological Preparations & Uses of Vitamin D

---

Synthesis of Vitamin D

Step 1: Skin (UV Light Required)

• 7-dehydrocholesterol (a cholesterol precursor present in cutaneous tissue) is converted to Cholecalciferol (Vitamin D3) by ultraviolet (UV) light
• UV irradiation cleaves the carbon-carbon bond at C9-C10, opening the B-ring to form cholecalciferol
• Cholecalciferol is the inactive precursor (prodrug form)
• Plant form: Ergocalciferol (Vitamin D2) is synthesized from ergosterol in plants by UV irradiation

Step 2: Liver Hydroxylation

• Cholecalciferol travels to the liver bound to vitamin D-binding globulin (transcalciferin)
• In hepatic microsomes, carbon 25 is hydroxylated by 25-hydroxylase enzyme
• Product: 25-hydroxycholecalciferol (Calcidiol / 25-OH-D3)
• This is the main circulating form of Vitamin D in the blood
• Calcidiol is present at ~100x higher concentration than calcitriol

Step 3: Kidney Hydroxylation (Rate-Limiting Step)

• In the proximal convoluted tubule, a mixed-function oxidase (requires O2 and NADPH) hydroxylates carbon 1 on the A ring
• Product: 1,25-dihydroxycholecalciferol (Calcitriol / 1,25-(OH)2-D3) - the most biologically active form
• This step is tightly regulated and is the rate-limiting step
• Parathyroid hormone (PTH) activates this final step - when Ca2+ falls, PTH rises, and calcitriol production increases

Calcitriol is approximately 100 times more potent than calcidiol

• Basic Medical Biochemistry - A Clinical Approach, p. 1221-1222

---

Absorption of Vitamin D

Dietary Sources:

• Found in fatty fish (salmon, mackerel, tuna), fish liver oils, egg yolks, fortified foods (milk, cereals)
• Two dietary forms: Vitamin D2 (ergocalciferol) from plants; Vitamin D3 (cholecalciferol) from animal sources

Absorption Mechanism:

• Vitamin D is a fat-soluble vitamin - absorbed in the small intestine along with dietary fats
• Requires bile salts (micelle formation) for efficient absorption
• Absorbed via chylomicrons into intestinal lymphatics, then into the bloodstream
• Transported in blood bound to vitamin D-binding protein (DBP/transcalciferin)
• Conditions causing fat malabsorption (e.g., celiac disease, Crohn's disease, cholestatic liver disease, cystic fibrosis) impair Vitamin D absorption

Mechanism of Action at Cellular Level:

• Being a steroid hormone, calcitriol diffuses passively through the plasma membrane
• Moves to the nucleus and binds to Vitamin D Receptor (VDR) - a nuclear receptor
• The calcitriol-VDR complex activates genes encoding calcium-transporting proteins
• In intestinal mucosal cells: activates genes for calcium-binding protein (calbindin) and other Ca2+/phosphorus transport proteins
• Results in increased absorption of calcium and phosphorus from the gut

---

Pharmacological Preparations and Uses

Available Preparations:

Therapeutic Uses:

Monitoring:

• Measure serum 25-OH-D3 (calcidiol) levels to assess Vitamin D status
• Normal range: 30-100 ng/mL
• Deficiency: < 20 ng/mL; Insufficiency: 20-30 ng/mL
• Toxicity (hypervitaminosis D): Hypercalcemia, hypercalciuria, soft tissue calcification - usually from excessive supplementation, not sun exposure (sun exposure self-limits by degrading excess precursors)
• Basic Medical Biochemistry - A Clinical Approach, p. 1221-1222; Costanzo Physiology 7th Edition

---